论文部分内容阅读
近期研究证明某些精神分裂症患者脑內多巴胺受体存在着超敏现象,从而使多巴胺受体与精神药理的研究受到重视。神经阻断药与放射性配基竞争性结合于多巴胺D_2受体的相对亲和力可能是预测临床疗效的有用指标。
Recent studies have shown that some patients with schizophrenia dopamine receptors in the brain there is a phenomenon of hypersensitivity, which makes dopamine receptors and psychopharmacology of attention. The relative affinity of blockers and radioligands for competitive binding to dopamine D2 receptors may be a useful predictor of clinical efficacy.